Skip to main content
. 2021 Feb 3;4(2):e2036330. doi: 10.1001/jamanetworkopen.2020.36330

Table 2. Complete Stratified Outcomes by Patient and Surgical Characteristicsa.

Characteristic Total sample (N = 608) Local recurrence Systemic recurrenceb
No (n = 586) Yes (n = 22) No (n = 526) Yes (n = 47)
Age, median (IQR), y 63 (54-70) 63 (54-70) 67 (47-74) 63 (54-70) 67 (52-72)
Sex
Female 185 (30.4) 179 (30.6) 6 (27.3) 156 (29.7) 14 (29.8)
Male 423 (69.6) 406 (69.4) 16 (72.7) 370 (70.3) 33 (70.2)
Body mass index
Underweight or normal 188 (30.9) 179 (30.6) 9 (40.9) 156 (29.7) 16 (34.0)
Overweight 226 (37.2) 215 (36.8) 10 (45.5) 194 (36.9) 21 (44.7)
Obese 194 (31.9) 191 (32.6) 3 (13.6) 176 (33.5) 10 (21.3)
Clinical AJCC stage
I 132 (21.7) 127 (21.7) 5 (22.7) 126 (24.0) 6 (12.8)
II 166 (27.3) 163 (27.9) 3 (13.6) 155 (29.5) 11 (23.4)
III 256 (42.1) 243 (41.5) 12 (54.5) 226 (43.0) 30 (63.8)
IV 35 (5.8) 33 (5.6) 2 (9.1) 0 0
Missing 19 (3.1) 19 (3.2) 0 19 (3.6) 0
Tumor height
Median (IQR), cm 6 (4-8) 6 (4-8) 5 (3-7) 6 (4-8) 6 (5-8)
Missing 11 (1.8) 11 (1.9) 0 9 (1.7) 0
Neoadjuvant therapy
No 183 (30.1) 175 (29.9) 8 (36.4) 170 (32.3) 9 (19.1)
Yes 425 (69.9) 410 (70.1) 14 (63.6) 356 (67.7) 38 (80.9)
Procedure
APR resection 44 (7.2) 41 (7.0) 3 (13.6) 40 (7.6) 4 (8.5)
LAR 559 (91.9) 539 (92.1) 19 (86.4) 481 (91.4) 43 (91.5)
Other 3 (0.5) 3 (0.5) 0 3 (0.6) 0
Missing 2 (0.3) 2 (0.3) 0 2 (0.4) 0
Anastomosis type
Handsewn 178 (29.3) 168 (28.7) 10 (45.5) 157 (29.8) 15 (31.9)
None 52 (8.6) 49 (8.4) 3 (13.6) 44 (8.4) 6 (12.8)
Stapled 371 (61.0) 362 (61.9) 8 (36.4) 319 (60.6) 26 (55.3)
Missing 7 (1.2) 6 (1.0) 1 (4.5) 6 (1.1) 0
Use of diverting ostomy
Any stoma 525 (86.3) 507 (86.7) 17 (77.3) 451 (85.7) 43 (91.5)
No stoma 71 (11.7) 67 (11.5) 4 (18.2) 63 (12.0) 4 (8.5)
Missing 12 (2.0) 11 (1.9) 1 (4.5) 12 (2.3) 0
Operative time
Median (IQR), min 276 (235-338) 276 (234-338) 300 (249-366) 275 (237-338) 290 (246-332)
Missing 3 (0.5) 3 (0.5) 0 2 (0.4) 0
Conversion
No 581 (95.6) 560 (95.7) 20 (90.9) 505 (96.0) 44 (93.6)
Yes 26 (4.3) 24 (4.1) 2 (9.1) 21 (4.0) 3 (6.4)
Missing 1 (0.2) 1 (0.2) 0 0 0
Intraoperative complications
No 575 (94.6) 552 (94.4) 22 (100) 495 (94.1) 46 (97.9)
Yes 30 (4.9) 30 (5.1) 0 29 (5.5) 0
Missing 3 (0.5) 3 (0.5) 0 2 (0.4) 1 (2.1)
Postoperative complications
No 269 (44.2) 262 (44.8) 7 (31.8) 228 (43.3) 21 (44.7)
Yes 339 (55.8) 323 (55.2) 15 (68.2) 298 (56.7) 26 (55.3)
Clavien-Dindo classification
1 108 (17.8) 102 (17.4) 5 (22.7) 99 (18.8) 5 (10.6)
2 135 (22.2) 131 (22.4) 4 (18.2) 117 (22.2) 11 (23.4)
3 88 (14.5) 83 (14.2) 5 (22.7) 75 (14.3) 9 (19.1)
4 5 (0.8) 4 (0.7) 1 (4.5) 4 (0.8) 1 (2.1)
5 3 (0.5) 3 (0.5) 0 3 (0.6) 0
Anastomotic leak
No 559 (91.9) 541 (92.5) 17 (77.3) 484 (92.0) 42 (89.4)
Yes 46 (7.6) 41 (7.0) 5 (22.7) 39 (7.4) 5 (10.6)
Missing 3 (0.5) 3 (0.5) 0 3 (0.6) 0
Another operation within 30 d
No 544 (89.5) 524 (89.6) 19 (86.4) 470 (89.4) 43 (91.5)
Yes 64 (10.5) 61 (10.4) 3 (13.6) 56 (10.6) 4 (8.5)
Readmission within 30 d
No 508 (83.6) 490 (83.8) 17 (77.3) 444 (84.4) 36 (76.6)
Yes 100 (16.4) 95 (16.2) 5 (22.7) 82 (15.6) 11 (23.4)
Quality of mesorectum
Incomplete 27 (4.4) 26 (4.4) 1 (4.5) 23 (4.4) 4 (8.5)
Complete 565 (92.9) 546 (93.3) 18 (81.8) 490 (93.2) 40 (85.1)
Missing 16 (2.6) 13 (2.2) 3 (13.6) 13 (2.5) 3 (6.4)
Circumferential radial margin
Positive 43 (7.1) 38 (6.5) 4 (18.2) 31 (5.9)c 10 (21.3)c
Negative 505 (83.1) 489 (83.6) 16 (72.7) 441 (83.8)c 35 (74.5)c
Missing 60 (9.9) 58 (9.9) 2 (9.1) 54 (10.3)c 2 (4.3)c
Distal radial margin
Positive 15 (2.5) 15 (2.6) 0 10 (1.9)d 4 (8.5)d
Negative 533 (87.7) 513 (87.7) 20 (90.9) 463 (88.0)d 41 (87.2)d
Missing 60 (9.9) 57 (9.7) 2 (9.1) 53 (10.1)d 2 (4.3)d
Local recurrence
No 585 (96.2) 585 (100)e 0e 518 (98.5)e 34 (72.3)e
Yes 22 (3.6) 0e 22 (100)e 7 (1.3)e 13 (27.7)e
Missing 1 (0.2) 0e 0e 1 (0.2)e 0e
Systemic recurrence
No 551 (90.6) 543 (92.8)e 7 (31.8)e 526 (100)e 0e
Yes 57 (9.4) 42 (7.2)e 15 (68.2)e 0e 47 (100)e
Follow-up, median (IQR), mo 27 (18-38) 27 (18-38) 36 (22-40) 27 (18-38) 34 (23-42)d

Abbreviations: AJCC, American Joint Committee on Cancer; APR, abdominoperineal; IQR, interquartile range; LAR, low anterior resection.

a

Data are presented as number (percentage) of patients unless otherwise indicated.

b

Stage IV cases (35) were not considered in the stratified analysis of systemic recurrence.

c

P = .001.

d

P < .05.

e

P < .001.